Skip to main content

Volume 12 Supplement 1

The role of IFN alpha in autoimmune disease

Reviews

Edited by Jean-Michel Dayer

Publication of the supplement has been supported with funding from MedImmune, LLC.

  1. Type I interferons are pleiotropic cytokines with antiviral, antitumor and immunoregulatory functions. An aspect of their complex biology is the paradox that, depending on context, type I interferons can be an...

    Authors: George D Kalliolias and Lionel B Ivashkiv
    Citation: Arthritis Research & Therapy 2010 12(Suppl 1):S1
    Content type: Review Published on:

  2. Type I interferons play an outstanding role in innate and adaptive immunity by enhancing functions of dendritic cells, inducing differentiation of monocytes, promoting immunoglobulin class switching in B cells...

    Authors: Angélica M Delgado-Vega, Marta E Alarcón-Riquelme and Sergey V Kozyrev
    Citation: Arthritis Research & Therapy 2010 12(Suppl 1):S2
    Content type: Review Published on:

  3. Patients with lupus have a continuous production of IFNα and display an increased expression of IFNα-regulated genes. The reason for the ongoing IFNα synthesis in these patients seems to be an activation of pl...

    Authors: Lars Rönnblom
    Citation: Arthritis Research & Therapy 2010 12(Suppl 1):S3
    Content type: Review Published on:

  4. Recent studies suggest a mechanistic role for molecules induced by type 1 interferons in the pathogenesis of some forms of myositis. For dermatomyositis, evidence that these molecules injure myofibers seems es...

    Authors: Steven A Greenberg
    Citation: Arthritis Research & Therapy 2010 12(Suppl 1):S4
    Content type: Review Published on:

  6. Type I interferons are implicated in the pathogenesis of systemic lupus erythematosus (SLE). Type I interferon-inducible mRNAs are widely and concordantly overexpressed in the periphery and involved tissues of...

    Authors: Yihong Yao, Brandon W Higgs, Laura Richman, Barbara White and Bahija Jallal
    Citation: Arthritis Research & Therapy 2010 12(Suppl 1):S6
    Content type: Review Published on:
  • Logo
Submit manuscript

Follow

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 4.4
    5-year Journal Impact Factor: 4.9
    Source Normalized Impact per Paper (SNIP): 1.294
    SCImago Journal Rank (SJR): 1.518

    Speed 2024
    Submission to first editorial decision (median days): 11
    Submission to acceptance (median days): 118

    Usage 2024
    Downloads: 3,978,337
    Altmetric mentions: 1,452

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us